Spinal cord astrocytes regulate myocardial ischemia-reperfusion injury.
Spinal cord astrocytes regulate myocardial ischemia-reperfusion injury.
复制标题
DOI:
10.1007/s00395-022-00968-x
复制
发表时间:
2022-11-11
影响因子:
9.5
通讯作者:
He S
中科院分区:
文献类型:
--
作者:
Wu C;Liu R;Luo Z;Sun M;Qile M;Xu S;Jin S;Zhang L;Gross ER;Zhang Y;He S
Astrocytes play a key role in the response to injury and noxious stimuli, but its role in myocardial ischemia–reperfusion (I/R) injury remains largely unknown. Here we determined whether manipulation of spinal astrocyte activity affected myocardial I/R injury and the underlying mechanisms. By ligating the left coronary artery to establish an in vivo I/R rat model, we observed a 1.7-fold rise in glial fibrillary acidic protein (GFAP) protein level in spinal cord following myocardial I/R injury. Inhibition of spinal astrocytes by intrathecal injection of fluoro-citrate, an astrocyte inhibitor, decreased GFAP immunostaining and reduced infarct size by 29% relative to the I/R group. Using a Designer Receptor Exclusively Activated by Designer Drugs (DREADD) chemogenetic approach, we bi-directionally manipulated astrocyte activity employing GFAP promoter-driven Gq- or Gi-coupled signaling. The Gq-DREADD-mediated activation of spinal astrocytes caused transient receptor potential vanilloid 1 (TRPV1) activation and neuropeptide release leading to a 1.3-fold increase in infarct size, 1.2-fold rise in serum norepinephrine level and higher arrhythmia score relative to I/R group. In contrast, Gi-DREADD-mediated inhibition of spinal astrocytes suppressed TRPV1-mediated nociceptive signaling, resulting in 35% reduction of infarct size and 51% reduction of arrhythmia score from I/R group, as well as lowering serum norepinephrine level from 3158 ± 108 to 2047 ± 95 pg/mL. Further, intrathecal administration of TRPV1 or neuropeptide antagonists reduced infarct size and serum norepinephrine level. These findings demonstrate a functional role of spinal astrocytes in myocardial I/R injury and provide a novel potential therapeutic approach targeting spinal cord astrocytes for the prevention of cardiac injury.
登录
查看更多内容
DOI:
10.1016/j.jacep.2021.05.016
发表时间:
2021-10
期刊:
JACC. Clinical electrophysiology
影响因子:
--
作者:
Howard-Quijano K;Yamaguchi T;Gao F;Kuwabara Y;Puig S;Lundquist E;Salavatian S;Taylor B;Mahajan A
通讯作者:
Mahajan A
DOI:
10.3390/molecules27031031
发表时间:
2022-02-03
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
Castrejón-Téllez V;Del Valle-Mondragón L;Pérez-Torres I;Guarner-Lans V;Pastelín-Hernández G;Ruiz-Ramírez A;Díaz-Juárez JA;Varela-López E;Oidor-Chan VH;Vargas-González A;Martínez-Memije R;Flores-Chávez P;León-Ruíz B;Arriaga-Carrillo S;Torres-Narváez JC
通讯作者:
Torres-Narváez JC
影响因子:
5.5
作者:
Domingues HS;Portugal CC;Socodato R;Relvas JB
通讯作者:
Relvas JB
影响因子:
9.5
作者:
Gross ER;Hsu AK;Urban TJ;Mochly-Rosen D;Gross GJ
通讯作者:
Gross GJ
影响因子:
9.5
作者:
Davidson SM;Arjun S;Basalay MV;Bell RM;Bromage DI;Bøtker HE;Carr RD;Cunningham J;Ghosh AK;Heusch G;Ibanez B;Kleinbongard P;Lecour S;Maddock H;Ovize M;Walker M;Wiart M;Yellon DM
通讯作者:
Yellon DM